These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11407226)

  • 21. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
    Lee MY; Seo CS; Lee NH; Ha H; Lee JA; Lee H; Lee KY; Shin HK
    Int Immunopharmacol; 2010 Nov; 10(11):1374-9. PubMed ID: 20727999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune modulation for treatment of allergic disease.
    Nguyen TH; Casale TB
    Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.
    van de Pol MA; Lutter R; van Ree R; van der Zee JS
    Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J; Dimov V; Townley RG
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model.
    Mo JH; Kang EK; Quan SH; Rhee CS; Lee CH; Kim DY
    Allergy; 2011 Feb; 66(2):279-86. PubMed ID: 21208219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation.
    Arestides RS; He H; Westlake RM; Chen AI; Sharpe AH; Perkins DL; Finn PW
    Eur J Immunol; 2002 Oct; 32(10):2874-80. PubMed ID: 12355440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newer therapies for asthma: a focus on anti-IgE.
    Babu KS; Holgate ST
    Indian J Chest Dis Allied Sci; 2002; 44(2):107-15. PubMed ID: 12026249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New advances in the pathogenesis and therapy of bronchial asthma.
    Ricci M; Matucci A; Rossi O
    Ann Ital Med Int; 1998; 13(2):93-110. PubMed ID: 9734142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophils as a pharmacological target for the treatment of allergic diseases.
    Landolina NA; Levi-Schaffer F
    Curr Opin Pharmacol; 2014 Aug; 17():71-80. PubMed ID: 25128782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of allergic diseases.
    Leung DY
    Mol Genet Metab; 1998 Mar; 63(3):157-67. PubMed ID: 9608537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting IgE in allergic disease.
    Gasser P; Eggel A
    Curr Opin Immunol; 2018 Oct; 54():86-92. PubMed ID: 29986302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Th17 and allergy.
    Oboki K; Ohno T; Saito H; Nakae S
    Allergol Int; 2008 Jun; 57(2):121-34. PubMed ID: 18427165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of polyphenols on allergic immune reactions: mechanisms of action.
    Magrone T; Jirillo E
    Proc Nutr Soc; 2012 May; 71(2):316-21. PubMed ID: 22369886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.
    Wegmann M
    Expert Rev Mol Diagn; 2009 Jan; 9(1):85-100. PubMed ID: 19099351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
    Barnes PJ
    Clin Exp Allergy; 2009 Aug; 39(8):1145-51. PubMed ID: 19538350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future treatments of allergic diseases and asthma.
    Stirling RG; Chung KF
    Br Med Bull; 2000; 56(4):1037-53. PubMed ID: 11359636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S; Richter D; Cepelak I; Benko B
    Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.